Ashwini Arunachalam

Merck & Co., Inc

Poster(s):

• (B-228) Evaluation of Database-Derived Real-World Disease-Free Survival (rwDFS) in Resected Non-Small Cell Lung Cancer (NSCLC)
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET